Cosmos Health Gets 180-Day Extension Through December 7 to Regain $1 Bid Compliance
COSM•Cosmos Health has been granted a 180-day extension through December 7, 2026 to meet Nasdaq’s $1.00 minimum bid price requirement after satisfying all other listing criteria. The company will focus on revenue growth, pipeline advancement and shareholder initiatives to restore compliance without resorting to a reverse stock split.
1. Extension Details
Cosmos Health has received a 180-day extension from Nasdaq through December 7, 2026 to satisfy the minimum $1.00 bid price requirement. This extension follows the company’s compliance with all other listing standards and provides additional time to restore the stock’s closing bid above the threshold for ten consecutive business days.
2. Compliance Plan
To regain compliance, the company will prioritize revenue growth and advancement of its pharmaceutical and nutraceutical pipeline. Management plans to implement shareholder value initiatives, including operational optimizations and potential strategic partnerships, aimed at driving sustained stock performance.
3. Reverse Split Contingency
While Cosmos Health retains the right to enact a reverse stock split if necessary, management regards this as a last-resort measure. The company’s leadership emphasized a preference for organic improvement over dilution from a share consolidation.
